BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12324513)

  • 1. Comparison of logistic regression and neural net modeling for prediction of prostate cancer pathologic stage.
    Veltri RW; Chaudhari M; Miller MC; Poole EC; O'Dowd GJ; Partin AW
    Clin Chem; 2002 Oct; 48(10):1828-34. PubMed ID: 12324513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study.
    Haese A; Chaudhari M; Miller MC; Epstein JI; Huland H; Palisaar J; Graefen M; Hammerer P; Poole EC; O'Dowd GJ; Partin AW; Veltri RW
    Cancer; 2003 Feb; 97(4):969-78. PubMed ID: 12569595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of prostate carcinoma stage by quantitative biopsy pathology.
    Veltri RW; Miller MC; Partin AW; Poole EC; O'Dowd GJ
    Cancer; 2001 Jun; 91(12):2322-8. PubMed ID: 11413521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy.
    Potter SR; Miller MC; Mangold LA; Jones KA; Epstein JI; Veltri RW; Partin AW
    Urology; 1999 Nov; 54(5):791-5. PubMed ID: 10565735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of neural networks and logistic regression analysis for predicting pathological stage in men undergoing radical prostatectomy: a population based study.
    Borque A; Sanz G; Allepuz C; Plaza L; Gil P; Rioja LA
    J Urol; 2001 Nov; 166(5):1672-8. PubMed ID: 11586200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
    Zlotta AR; Remzi M; Snow PB; Schulman CC; Marberger M; Djavan B
    J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma.
    Han M; Snow PB; Brandt JM; Partin AW
    Cancer; 2001 Apr; 91(8 Suppl):1661-6. PubMed ID: 11309765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen and Gleason score to predict prostate cancer stage.
    Poulakis V; Witzsch U; De Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    J Urol; 2004 Oct; 172(4 Pt 1):1306-10. PubMed ID: 15371829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial neural network for predicting pathological stage of clinically localized prostate cancer in a Taiwanese population.
    Tsao CW; Liu CY; Cha TL; Wu ST; Sun GH; Yu DS; Chen HI; Chang SY; Chen SC; Hsu CY
    J Chin Med Assoc; 2014 Oct; 77(10):513-8. PubMed ID: 25175002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?
    Pepe P; Fraggetta F; Galia A; Grasso G; Piccolo S; Aragona F
    Urology; 2008 Dec; 72(6):1198-202. PubMed ID: 19041023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of different variables on the outcome of patients with clinically confined prostate carcinoma: prediction of pathologic stage and biochemical failure using an artificial neural network.
    Ziada AM; Lisle TC; Snow PB; Levine RF; Miller G; Crawford ED
    Cancer; 2001 Apr; 91(8 Suppl):1653-60. PubMed ID: 11309764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning for improved pathological staging of prostate cancer: a performance comparison on a range of classifiers.
    Regnier-Coudert O; McCall J; Lothian R; Lam T; McClinton S; N'dow J
    Artif Intell Med; 2012 May; 55(1):25-35. PubMed ID: 22206941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks.
    Tewari A; Narayan P
    J Urol; 1998 Aug; 160(2):430-6. PubMed ID: 9679892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Ki-67 staining improve quantitative histology in preoperative prostate cancer staging?
    Pepe P; Fraggetta F; Candiano G; Aragona F
    Arch Ital Urol Androl; 2012 Mar; 84(1):32-5. PubMed ID: 22649958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy.
    Cantiello F; Russo GI; Ferro M; Cicione A; Cimino S; Favilla V; PerdonĂ  S; Bottero D; Terracciano D; De Cobelli O; Morgia G; Damiano R
    Urol Oncol; 2015 Apr; 33(4):163.e15-23. PubMed ID: 25575715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial neural network analysis for predicting pathological stage of clinically localized prostate cancer in the Japanese population.
    Matsui Y; Egawa S; Tsukayama C; Terai A; Kuwao S; Baba S; Arai Y
    Jpn J Clin Oncol; 2002 Dec; 32(12):530-5. PubMed ID: 12578902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.
    Gupta RT; Faridi KF; Singh AA; Passoni NM; Garcia-Reyes K; Madden JF; Polascik TJ
    Urol Oncol; 2014 Nov; 32(8):1292-9. PubMed ID: 24863013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy.
    Khan MA; Walsh PC; Miller MC; Bales WD; Epstein JI; Mangold LA; Partin AW; Veltri RW
    Cancer; 2003 Dec; 98(12):2583-91. PubMed ID: 14669277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.